Appreciating the Impact of Tacrolimus Sampling Time Deviations in Pediatric Patients With Nephrotic Syndrome

Ther Drug Monit. 2020 Jun;42(3):354-356. doi: 10.1097/FTD.0000000000000742.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Area Under Curve
  • Child
  • Cytochrome P-450 CYP3A / genetics
  • Drug Monitoring / methods*
  • Humans
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Nephrotic Syndrome / drug therapy*
  • Tacrolimus / pharmacokinetics
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Cytochrome P-450 CYP3A
  • Tacrolimus